AUG 27, 2019 3:30 PM PDT

Why Drugs that Work on Mice Don't Work on Humans

WRITTEN BY: Annie Lennon

Mice are used as the frontline for drug testing for brain disorders. Why? Their brains are supposed to have much of the same functioning as ours. Moreover, their shorter lifespans and fast reproduction cycles mean that we can easily measure the lifetime and transgenerational effects of new drugs on them. However, drugs that work in mice do not always work on humans in the same way. 

Neuropsychiatric drug development is “in the midst of a crisis”. This is because, for every 100 neuropsychiatric drugs tested in clinical trials for ailments from autism and depression to Alzheimer’s, only nine end up as approved medications, one of the lowest approval rates across disease categories. And this comes despite working on mice (Begley: 2019). 

To understand why this is the case, a team of neuroscientists from the Allen Institute for Brain Science in Seattle used a new procedure, known as a single-nucleus RNA-sequencing analysis, to study the medial temporal gyrus, the area of the brain involved in language processing and deductive reasoning, in both humans and mice (Hodge: 2019). 

Analyzing a total of eight brains either donated by deceased people or by epilepsy patients after brain surgery, the researchers worked through almost 16,000 cells to identify 75 different cell types. Although the data set they had from mice matched their human findings almost completely, they found that when they looked more closely at the genes that were switched on or off inside those cells, stark differences between human and mouse brains arose (Saplakoglu: 2019). 

In particular, the research demonstrated large differences in neurotransmitter receptors between humans and mice, an area that has been very active in drug discovery. Although both species have these receptors, they’re expressed via different types of cell. This means that, although these neurotransmitters exist in both humans and mice, they have very different functions, putting serotonin-based drugs such as antidepressants including Prozac under even more scrutiny. After all, drugs such as this that tamper with serotonin levels in the brain likely work on different cells in mice than in humans.  

Other significant differences between mice and human brains were found in genes coding for ion channels, which interconnect neurons by controlling the electrical potential across membranes (Lowe: 2019). Also an area that has undergone a lot of study for drug discovery for ailments including neuropathic pain and cardiovascular problems, this research further demonstrates why positive results in treatments for these conditions in mouse experiments may not have been translated over to humans. 

According to co-senior author of the study, Christof Koch, these findings demonstrate one thing clearly: “If you want to cure human brain diseases, you have to understand the uniqueness of the human brain.” To this end, with the aid of new technological advancements capable of identifying certain cellular differences, the researchers hope to be able to better identify human disorders and distinguish how relevant mouse or monkey models for drug discovery will be before trials are conducted. 

 

Sources

 

Begley, Sharon: Statnews

Hodge, Rebecca D. et al. : Nature

Saplakoglu, Yasemin: Live Science 

Lowe, Derek: Science Translational Medicine 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 29, 2020
Cardiology
Improving Acute Myocardial Ischemia Treatment with Nitro Fatty Acids
SEP 29, 2020
Improving Acute Myocardial Ischemia Treatment with Nitro Fatty Acids
Acute myocardial ischemia occurs when blood flow is restricted in the heart. This usually leads to cardiovascular issues ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...